A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Vaccine

• Publication date

  2012-02-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.vaccine.2011.12.078PMID 22212129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection.

  2010cited by this paper
• Plasmid DNA of high quality purified by activated charcoal.

  2010cited by this paper
• DNA vaccines for targeting bacterial infections

  2010cited by this paper
• Predicted no effect concentration (PNEC) for triclosan to terrestrial species (invertebrates and plants).

  2010cited by this paper
• Improved antibiotic-free DNA vaccine vectors utilizing a novel RNA based plasmid selection system.

  2009cited by this paper
• Engineering of bacterial strains and vectors for the production of plasmid DNA

  2009cited by this paper
• Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.

  2009cited by this paper
• Noncarrier naked antigen-specific DNA vaccine generates potent antigen-specific immunologic responses and antitumor effects

  2009cited by this paper
• Plasmid DNA vaccine vector design: impact on efficacy, safety and upstream production.

  2009cited by this paper
• DNA vaccines in veterinary use

  2009cited by this paper
• A small step closer to the Holy Grail of DNA vaccines: undisputed clinical benefit in humans

  2009cited by this paper
• Vaccines for Multiple Sclerosis

  2008cited by this paper
• A novel antibiotic free plasmid selection system: Advances in safe and efficient DNA therapy

  2008cited by this paper
• DNA vaccines: ready for prime time?

  2008cited by this paper
• Plasmid selection in Escherichia coli using an endogenous essential gene marker

  2008cited by this paper
• Selective enzyme-linked immunosorbent assay for triclosan. Application to wastewater treatment plant effluents.

  2008cited by this paper
• Prolonged treatment of Salmonella enterica serovar Typhimurium with commercial disinfectants selects for multiple antibiotic resistance, increased efflux and reduced invasiveness.

  2007cited by this paper
• Bovine viral diarrhoea virus (BVDV) diversity and vaccination. A review

  2007cited by this paper
• Measurement of triclosan in water using a magnetic particle enzyme immunoassay.

  2007cited by this paper
• The control of bovine viral diarrhoea virus in Europe: today and in the future.

  2006cited by this paper
• Resistance in gram-negative bacteria: Enterobacteriaceae.

  2006cited by this paper
• Resistance in gram-negative bacteria: enterobacteriaceae.

  2006cited by this paper
• Glycoprotein E2 of bovine viral diarrhea virus expressed in insect cells provides calves limited protection from systemic infection and disease

  2005cited by this paper
• Adaptive Resistance to Biocides in Salmonella enterica and Escherichia coli O157 and Cross-Resistance to Antimicrobial Agents

  2004cited by this paper
• DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge.

  2003cited by this paper
• Exposure of Sink Drain Microcosms to Triclosan: Population Dynamics and Antimicrobial Susceptibility

  2003cited by this paper
• Investigation of antibiotic and antibacterial agent cross‐resistance in target bacteria from homes of antibacterial product users and nonusers

  2003cited by this paper
• Molecular Cloning: A Laboratory Manual

  2001cited by this paper
• Cross-Resistance between Triclosan and Antibiotics inPseudomonas aeruginosa Is Mediated by Multidrug Efflux Pumps: Exposure of a Susceptible Mutant Strain to Triclosan Selects nfxB Mutants Overexpressing MexCD-OprJ

  2001cited by this paper
• Escherichia coli strains that allow antibiotic-free plasmid selection and maintenance by repressor titration.

  2001cited by this paper
• Cytokine adjuvancy of BVDV DNA vaccine enhances both humoral and cellular immune responses in mice.

  2001cited by this paper
• Co-administration of IL-2 enhances antigen-specific immune responses following vaccination with DNA encoding the glycoprotein E2 of bovine viral diarrhoea virus.

  2000cited by this paper
• Mechanism of Triclosan Inhibition of Bacterial Fatty Acid Synthesis*

  1999cited by this paper
• Functional analysis of antibody responses of feedlot cattle to bovine respiratory syncytial virus following vaccination with mixed vaccines.

  1997cited by this paper
• Cloning of a DNA sequence that complements glutamine auxotrophy in Saccharomyces cerevisiae.

  1985cited by this paper

• Resistome analysis of Escherichia coli isolates from layers in Hungary.

  2024cites this paper
• DNA Vaccines: A Promising Vaccine for the Future

  2021cites this paper
• The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines.

  2019cites this paper
• Detection of bovine viral diarrhoea virus nucleic acid, but not infectious virus, in bovine serum used for human vaccine manufacture.

  2018cites this paper
• DNA Vaccine: The Third Generation Vaccine

  2016cites this paper
• The efficacy of an inhibin DNA vaccine delivered by attenuated Salmonella choleraesuis on follicular development and ovulation responses in crossbred buffaloes.

  2016cites this paper
• Use of FabV-Triclosan Plasmid Selection System for Efficient Expression and Production of Recombinant Proteins in Escherichia coli

  2015cites this paper
• FabV/Triclosan Is an Antibiotic-Free and Cost-Effective Selection System for Efficient Maintenance of High and Medium -Copy Number Plasmids in Escherichia coli

  2015cites this paper
• Enhanced neutralising antibody response to bovine viral diarrhoea virus (BVDV) induced by DNA vaccination in calves.

  2015cites this paper
• Construction of Escherichia coli strains for higher plasmid production : Evaluation of lon gene knockout and implementation of a marker-free system

  2014cites this paper
• Efficacy and Safety of an Oral Somatostatin DNA Vaccine without Antibiotic Resistance Gene in Promoting Growth of Piglets

  2014cites this paper
• Development of new tools for the production of plasmid DNA biopharmaceuticals

  2012cites this paper